101 related articles for article (PubMed ID: 24666252)
41. Co-ordinate expression of T-cell antigens on acute myelogenous leukemia and of myeloid antigens on T-acute lymphoblastic leukemia. Speculation on a highly balanced bilinearity.
Del Vecchio L; Finizio O; Lo Pardo C; Pane N; Schiavone EM; Vacca C; Ferrara F
Leukemia; 1991 Sep; 5(9):815-8. PubMed ID: 1719310
[No Abstract] [Full Text] [Related]
42. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
[TBL] [Abstract][Full Text] [Related]
43. Childhood acute myeloid leukemias expressing lymphoid-associated antigens.
Schaison GS
Pediatr Hematol Oncol; 1995; 12(5):413-5. PubMed ID: 8519622
[No Abstract] [Full Text] [Related]
44. Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.
Lamble AJ; Dietz M; Laderas T; McWeeney S; Lind EF
J Immunol Methods; 2018 Feb; 453():44-52. PubMed ID: 29175391
[TBL] [Abstract][Full Text] [Related]
45. Improving prediction accuracy in acute myeloid leukaemia: micro-environment, immune and metabolic models.
Hu F; Wang Y; Wang WD; Gale RP; Wu BY; Liang Y
Leukemia; 2021 Nov; 35(11):3073-3077. PubMed ID: 34365474
[No Abstract] [Full Text] [Related]
46. Comment on "High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma".
Antonioli L; di Paolo A; Fornai M; Danesi R; Blandizzi C
Tumour Biol; 2015 Sep; 36(10):7397-8. PubMed ID: 26383525
[No Abstract] [Full Text] [Related]
47. [CD-markers in the practice of clinical diagnostic laboratories (Lecture)].
Cheredeev AN; Gorlina NK; Kozlov IG
Klin Lab Diagn; 1999 Jun; (6):25-32. PubMed ID: 10459202
[No Abstract] [Full Text] [Related]
48. Temperature coefficients of muscle apyrase systems.
STEINBACH HB
J Cell Comp Physiol; 1949 Feb; 33(1):123-31. PubMed ID: 18116714
[No Abstract] [Full Text] [Related]
49. Temperature coefficients of apyrase systems from muscles of different animals.
STEINBACH HB
Biol Bull; 1948 Oct; 95(2):287. PubMed ID: 18887896
[No Abstract] [Full Text] [Related]
50. Calcium and apyrase system of muscle.
STEINBACH HB
Arch Biochem; 1949 Jun; 22(2):328-30. PubMed ID: 18131431
[No Abstract] [Full Text] [Related]
51. The apyrase activity of various protein fractions of the frog's egg.
BARTH LG; JAEGER L
J Cell Comp Physiol; 1947 Oct; 30(2):111-30. PubMed ID: 20267754
[No Abstract] [Full Text] [Related]
52. Thermal enzymes. III. Apyrase from a thermophilic Bacterium.
MILITZER W; TUTTLE LC; GEORGI CE
Arch Biochem Biophys; 1951 May; 31(3):416-23. PubMed ID: 14830256
[No Abstract] [Full Text] [Related]
53. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
54. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
[TBL] [Abstract][Full Text] [Related]
55. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
[TBL] [Abstract][Full Text] [Related]
56. High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.
Aliagas E; Vidal A; Texidó L; Ponce J; Condom E; Martín-Satué M
Mediators Inflamm; 2014; 2014():509027. PubMed ID: 24707115
[TBL] [Abstract][Full Text] [Related]
57. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults.
Talleur AC; Fabrizio VA; Aplenc R; Grupp SA; Mackall C; Majzner R; Nguyen R; Rouce R; Moskop A; McNerney KO
Transplant Cell Ther; 2024 Jun; 30(6):565-579. PubMed ID: 38588880
[TBL] [Abstract][Full Text] [Related]
58. Metabolic instruction of the graft-versus-leukemia immunity.
Burk AC; Apostolova P
Front Immunol; 2024; 15():1347492. PubMed ID: 38500877
[TBL] [Abstract][Full Text] [Related]
59. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T; Velázquez GF; Schmid C
Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
[TBL] [Abstract][Full Text] [Related]
60. The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Jiang X; Wu X; Xiao Y; Wang P; Zheng J; Wu X; Jin Z
Front Immunol; 2023; 14():1110325. PubMed ID: 36776866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
